Revolution Medicines has zeroed in on Iambic Therapeutics’ AI drug discovery platform, striking a multi-year technology and research collaboration that gives Iambic the chance to earn up to $25 mil | ...

Meta Platforms has gained over 1,200% since 2012. The company is now investing heavily in artificial intelligence, bolstering ...

The course builds on my 2018 class, Art and Geometry, which I co-taught with local artists. The course explored Picasso’s cubism, which depicted reality as fractured from multiple perspectives; it ...

Unlike traditional models, AiDE® combines AI-driven execution with human-like planning, resulting in better accuracy, fewer ...

Iambic to receive up to $25 million through a combination of upfront and expected near-term performance-based milestone payments for services related to Revolution Medicines’ access to Iambic’s ...

Investor attention is once again drifting toward Aptos and Ethereum as charts present more favorable price patterns. Yet Ozak ...

Revolution Medicine’s proprietary data will train a bespoke version of NeuralPLexer, an AI model for protein-ligand prediction from Iambic.

AI isn't just changing how most industries operate, but it could also change the scale of financial outcomes from running a ...

Nvidia’s revenue has soared in recent years thanks to the company’s dominance in the AI market. Nvidia (NASDAQ: NVDA) has ...

Just about every big tech company in the world is in a race to build more computing capacity than anyone else in order to ...

MIT economist David Autor warns that AI could devalue skills, leading to a 'Mad Max' labor market with concentrated wealth ...

The country is laying the groundwork for a profound long-term transformation. Moving beyond reactive fiscal tightening and ...